SEOM 皮肤黑色素瘤治疗临床指南(2020)

2021-03-12 西班牙肿瘤内科学会 Clinical and Translational Oncology

在西班牙,黑色素瘤每年影响约 6000 名患者。来自西班牙肿瘤内科学会 (SEOM) 和西班牙多学科黑色素瘤组 (GEM) 的一组医学肿瘤学家设计了这些指南,以统一对这些患者的管理。

中文标题:

SEOM 皮肤黑色素瘤治疗临床指南(2020)

发布日期:

2021-03-12

简要介绍:

在西班牙,黑色素瘤每年影响约 6000 名患者。来自西班牙肿瘤内科学会 (SEOM) 和西班牙多学科黑色素瘤组 (GEM) 的一组医学肿瘤学家设计了这些指南,以统一对这些患者的管理。诊断必须是组织学的,并且必须在 ≥ III 期的患者中确定 BRAF 状态。I-III 期可切除的黑色素瘤将通过手术治疗。对于 III 期黑色素瘤患者,还建议进行免疫治疗或靶向治疗的辅助治疗。不可切除或转移性黑色素瘤患者将接受免疫治疗或靶向治疗,这些治疗的最佳顺序尚不清楚。脑转移需要单独考虑,因为除了全身治疗外,还可能需要局部治疗。

相关资料下载:
[AttachmentFileName(sort=1, fileName=SEOM 皮肤黑色素瘤治疗临床指南(2020).pdf)] GetToolGuiderByIdResponse(projectId=1, id=517841c00229623c, title=SEOM 皮肤黑色素瘤治疗临床指南(2020), enTitle=, guiderFrom=Clinical and Translational Oncology, authorId=0, author=, summary=在西班牙,黑色素瘤每年影响约 6000 名患者。来自西班牙肿瘤内科学会 (SEOM) 和西班牙多学科黑色素瘤组 (GEM) 的一组医学肿瘤学家设计了这些指南,以统一对这些患者的管理。, cover=https://img.medsci.cn/20211219/1639890667542_5579292.png, journalId=0, articlesId=null, associationId=2142, associationName=西班牙肿瘤内科学会 , associationIntro=西班牙肿瘤内科学会 (SEOM) , copyright=0, guiderPublishedTime=Fri Mar 12 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">在西班牙,黑色素瘤每年影响约 6000 名患者。</span><span style="color: #333333;">来自西班牙肿瘤内科学会 (SEOM) 和西班牙多学科黑色素瘤组 (GEM) 的一组医学肿瘤学家设计了这些指南,以统一对这些患者的管理。</span><span style="color: #333333;">诊断必须是组织学的,并且必须在 &ge; III 期的患者中确定 BRAF 状态。</span><span style="color: #333333;">I-III 期可切除的黑色素瘤将通过手术治疗。</span><span style="color: #333333;">对于 III 期黑色素瘤患者,还建议进行免疫治疗或靶向治疗的辅助治疗。</span><span style="color: #333333;">不可切除或转移性黑色素瘤患者将接受免疫治疗或靶向治疗,这些治疗的最佳顺序尚不清楚。</span><span style="color: #333333;">脑转移需要单独考虑,因为除了全身治疗外,还可能需要局部治疗。</span></p>, tagList=[TagDto(tagId=27275, tagName=恶性黑色素瘤), TagDto(tagId=49060, tagName=皮肤黑色素瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=49060, guiderKeyword=皮肤黑色素瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2270, appHits=123, showAppHits=0, pcHits=292, showPcHits=2147, likes=0, shares=17, comments=10, approvalStatus=1, publishedTime=Sun Dec 19 13:07:38 CST 2021, publishedTimeString=2021-03-12, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Dec 19 13:16:45 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Tue Jan 02 07:21:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=SEOM 皮肤黑色素瘤治疗临床指南(2020).pdf)])
SEOM 皮肤黑色素瘤治疗临床指南(2020).pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1218959, encodeId=60c61218959a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:51:02 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200281, encodeId=2de712002818a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:37:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200279, encodeId=8ba312002e9f9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:34:14 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192188, encodeId=3bf11192188d0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97362170587, createdName=1204f8fdm67(暂无昵称), createdTime=Fri Feb 11 08:51:03 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186650, encodeId=a9db11866509c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f7d5228703, createdName=14796d72m27暂无昵称, createdTime=Fri Jan 21 00:02:15 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-05-12 ms5000001683434619

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1218959, encodeId=60c61218959a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:51:02 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200281, encodeId=2de712002818a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:37:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200279, encodeId=8ba312002e9f9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:34:14 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192188, encodeId=3bf11192188d0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97362170587, createdName=1204f8fdm67(暂无昵称), createdTime=Fri Feb 11 08:51:03 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186650, encodeId=a9db11866509c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f7d5228703, createdName=14796d72m27暂无昵称, createdTime=Fri Jan 21 00:02:15 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-03-07 ms5000000926182932

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1218959, encodeId=60c61218959a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:51:02 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200281, encodeId=2de712002818a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:37:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200279, encodeId=8ba312002e9f9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:34:14 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192188, encodeId=3bf11192188d0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97362170587, createdName=1204f8fdm67(暂无昵称), createdTime=Fri Feb 11 08:51:03 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186650, encodeId=a9db11866509c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f7d5228703, createdName=14796d72m27暂无昵称, createdTime=Fri Jan 21 00:02:15 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-03-07 ms5000000926182932

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1218959, encodeId=60c61218959a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:51:02 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200281, encodeId=2de712002818a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:37:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200279, encodeId=8ba312002e9f9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:34:14 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192188, encodeId=3bf11192188d0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97362170587, createdName=1204f8fdm67(暂无昵称), createdTime=Fri Feb 11 08:51:03 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186650, encodeId=a9db11866509c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f7d5228703, createdName=14796d72m27暂无昵称, createdTime=Fri Jan 21 00:02:15 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-02-11 1204f8fdm67(暂无昵称)

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1218959, encodeId=60c61218959a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:51:02 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200281, encodeId=2de712002818a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:37:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200279, encodeId=8ba312002e9f9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df586539980, createdName=ms5000000926182932, createdTime=Mon Mar 07 17:34:14 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192188, encodeId=3bf11192188d0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97362170587, createdName=1204f8fdm67(暂无昵称), createdTime=Fri Feb 11 08:51:03 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186650, encodeId=a9db11866509c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f7d5228703, createdName=14796d72m27暂无昵称, createdTime=Fri Jan 21 00:02:15 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-01-21 14796d72m27暂无昵称

    学习

    0

拓展阅读

2015 ESMO临床实践指南:皮肤黑色素瘤的诊断、治疗与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2015-09-01

2018 SITC共识声明:皮肤黑色素瘤的免疫治疗(更新版)

肿瘤免疫治疗学会(SITC,Society for Immunotherapy of Cancer) · 2018-05-30

2018 英国共识声明:前哨淋巴结活检在皮肤黑色素瘤管理中的作用

国外肿瘤科相关专家小组(统称) · 2019-07-28

2019 JDA指南:皮肤黑色素瘤(概述)

日本皮肤病协会(JDA,Japanese Dermatological Association) · 2019-11-28

2023 SIGN国家临床指南:皮肤黑色素瘤-修订版(146)

苏格兰校际指南网络(SIGN,Scottish Intercollegiate Guidelines Network) · 2023-08-10